Toward universal vaccination against hepatitis B virusHOOFNAGLE, J. H.The New England journal of medicine. 1989, Vol 321, Num 19, pp 1333-1334, issn 0028-4793, 2 p.Article

Chronic hepatitis BHOOFNAGLE, J. H.The New England journal of medicine. 1990, Vol 323, Num 5, pp 337-339, issn 0028-4793Article

Ground rounds at the clinical center of the national institutes of health. Type D (delta) hepatitisHOOFNAGLE, J. H.JAMA, the journal of the American Medical Association. 1989, Vol 261, Num 9, pp 1321-1325, issn 0098-7484Article

Management of hepatitis C : current and future perspectivesHOOFNAGLE, J. H.Journal of hepatology. Supplement. 1999, Vol 31, Num 1, pp 264-268, issn 0169-5185Conference Paper

Hepatitis C : The clinical spectrum of diseaseHOOFNAGLE, J. H.Hepatology (Baltimore, Md.). 1997, Vol 26, Num 3, pp 15S-20S, issn 0270-9139, SUP1Conference Paper

Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitisSJOGREN, M; HOOFNAGLE, J. H.Gastroenterology (New York, NY. 1943). 1985, Vol 89, Num 2, pp 252-258, issn 0016-5085Article

Antiviral therapy of chronic viral hepatitisDI BISCEGLIE, M; HOOFNAGLE, J. H.The American journal of gastroenterology. 1990, Vol 85, Num 6, pp 650-654, issn 0002-9270, 5 p.Article

Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: relationship to cirrhosisWILLIAMS, A. L. B; HOOFNAGLE, J. H.Gastroenterology (New York, NY. 1943). 1988, Vol 95, Num 3, pp 734-739, issn 0016-5085Article

α-Interferon therapy of chronic hepatitis B. Current status and recommendationsHOOFNAGLE, J. H.Journal of hepatology. 1990, Vol 11, pp S100-S107, issn 0168-8278, SUP1Conference Paper

Phenytoin hepatotoxicity masked by corticosteroidsLISKER-MELMAN, M; HOOFNAGLE, J. H.Archives of internal medicine (1960). 1989, Vol 149, Num 5, pp 1196-1197, issn 0003-9926, 2 p.Article

Drug therapy : The treatment of chronic viral hepatitisHOOFNAGLE, J. H; DI BISCEGLIE, A. M.The New England journal of medicine. 1997, Vol 336, Num 5, pp 347-356, issn 0028-4793Article

Reactivation of chronic type B hepatitis presenting as acute viral hepatitisDAVIS, G. L; HOOFNAGLE, J. H.Annals of internal medicine. 1985, Vol 102, Num 6, pp 762-765, issn 0003-4819Article

Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis BDE BISCEGLIE, A. M; HOOFNAGLE, J. H.Cancer. 1989, Vol 64, Num 10, pp 2117-2120, issn 0008-543XArticle

Chronic type B hepatitis and the healthy HBsAg carrier stateHOOFNAGLE, J. H; SHAFRITZ, D. A; POPPER, H et al.Hepatology (Baltimore, Md.). 1987, Vol 7, Num 4, pp 758-763, issn 0270-9139Article

Hepatic inclusions during interferon therapy in chronic viral hepatitisSCHAFF, Z; HOOFNAGLE, J. H; GRIMLEY, P. M et al.Hepatology (Baltimore, Md.). 1986, Vol 6, Num 5, pp 966-970, issn 0270-9139Article

Antibody to the hepatitis B virus-associated delta-agent in immune serum globulinsPONZETTO, A; HOOFNAGLE, J. H; SEEFF, L. B et al.Gastroenterology (New York, NY. 1943). 1984, Vol 87, Num 6, pp 1213-1216, issn 0016-5085Article

Conditions associated with hepatocellular carcinomaLISKER-MELMAN, M; MARTIN, P; HOOFNAGLE, J. H et al.The Medical clinics of North America. 1989, Vol 73, Num 4, pp 999-1009, issn 0025-7125, 11 p.Article

Relation of the hepatitis B virus carrier state to hepatocellular carcinomaPOPPER, H; SHAFRITZ, D. A; HOOFNAGLE, J. H et al.Hepatology (Baltimore, Md.). 1987, Vol 7, Num 4, pp 764-772, issn 0270-9139Article

Therapy of viral hepatitisHOOFNAGLE, J. H.Digestion. 1998, Vol 59, Num 5, pp 563-578, issn 0012-2823Conference Paper

Shock wave-induced pancreatic traumaMULLEN, K. D; HOOFNAGLE, J. H; JONES, E. A et al.The American journal of gastroenterology. 1991, Vol 86, Num 5, pp 630-632, issn 0002-9270, 3 p.Article

Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitisSJOGREN, M. H; HOOFNAGLE, J. H; WAGGONER, J. G et al.Hepatology (Baltimore, Md.). 1987, Vol 7, Num 3, pp 582-585, issn 0270-9139Article

Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers: correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapyDI BISCEGLIE, A. M; WAGGONER, J. G; HOOFNAGLE, J. H et al.Gastroenterology (New York, NY. 1943). 1987, Vol 93, Num 6, pp 1236-1241, issn 0016-5085Article

Changes in hepatitis C virus antigen in liver with antiviral therapyDI BISCEGLIE, A. M; HOOFNAGLE, J. H; KRAWCZYNSKI, K et al.Gastroenterology (New York, NY. 1943). 1993, Vol 105, Num 3, pp 858-862, issn 0016-5085Article

Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitisHANSON, R. G; PETERS, M. G; HOOFNAGLE, J. H et al.Hepatology (Baltimore, Md.). 1986, Vol 6, Num 2, pp 173-179, issn 0270-9139Article

Long-term follow-up of patients with chronic hepatitis C treated with α-interferonSHINDO, M; DI BISCEGLIE, A. M; HOOFNAGLE, J. H et al.Hepatology (Baltimore, Md.). 1992, Vol 15, Num 6, pp 1013-1016, issn 0270-9139Article